J M Ribera Selected Research

J M Ribera Research Topics

Disease

4	Neoplasms (Cancer) 01/2022 - 03/2001
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2015 - 10/2005
3	Acute Promyelocytic Leukemia 01/2018 - 08/2001
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2017 - 06/2001
2	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2022 - 01/2000
2	Residual Neoplasm 01/2018 - 06/2010
2	Leukemia 04/2017 - 04/2014
2	Multiple Myeloma 01/2007 - 01/2001
2	Chromosome Aberrations (Chromosome Abnormalities) 08/2001 - 05/2000
2	Acquired Immunodeficiency Syndrome (AIDS) 03/2001 - 01/2000
1	Lymphoma (Lymphomas) 01/2021
1	Mycosis Fungoides 01/2021
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2018
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 04/2017
1	Tumor Lysis Syndrome 10/2015
1	Hematologic Neoplasms (Hematological Malignancy) 10/2015
1	Neutropenia 03/2011
1	Autoimmune Diseases (Autoimmune Disease) 03/2009
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 05/2008
1	Pathologic Complete Response 07/2001
1	Central Nervous System Diseases (CNS Diseases) 06/2001
1	Healthcare-Associated Pneumonia 05/2001
1	Pneumonia (Pneumonitis) 05/2001
1	Respiratory Insufficiency (Respiratory Failure) 05/2001
1	Agammaglobulinemia (Hypogammaglobulinemia) 05/2001
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 05/2001
1	Agranulocytosis (Granulocytopenia) 05/2001
1	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 03/2001
1	Opportunistic Infections (Opportunistic Infection) 03/2001
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2001
1	Thrombocytopenia (Thrombopenia) 01/2001
1	Hemorrhage 10/2000
1	Venous Thrombosis (Deep-Vein Thrombosis) 10/2000
1	Venous Thromboembolism 10/2000
1	T-Cell Lymphoma (Lymphoma, T Cell) 03/2000
1	Hodgkin Disease (Hodgkin's Disease) 01/2000
1	Anemia 01/2000
1	Hemolytic Anemia 01/2000

Drug/Important Bio-Agent (IBA)

4	Biological ProductsIBA 10/2015 - 01/2000
3	Prednisone (Sone)FDA LinkGeneric 05/2001 - 01/2001
2	AnthracyclinesIBA 01/2018 - 08/2001
2	MicroRNAs (MicroRNA)IBA 10/2015 - 04/2014
1	Azacitidine (5 Azacytidine)FDA Link 01/2022
1	Gemtuzumab (Mylotarg)FDA Link 04/2017
1	RNA (Ribonucleic Acid)IBA 01/2017
1	mRNA decapping enzymesIBA 01/2017
1	Uric Acid (Urate)IBA 10/2015
1	Allopurinol (Remid)FDA LinkGeneric 10/2015
1	Febuxostat FDA Link 10/2015
1	Histone Deacetylase InhibitorsIBA 07/2012
1	PanobinostatIBA 07/2012
1	Therapeutic UsesIBA 07/2012
1	CTLA-4 AntigenIBA 03/2009
1	beta-Lactamases (beta-Lactamase)IBA 11/2008
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2006
1	Monoclonal AntibodiesIBA 10/2005
1	Protein Isoforms (Isoforms)IBA 07/2001
1	Methotrexate (Mexate)FDA LinkGeneric 06/2001
1	Chlorambucil (Leukeran)FDA Link 05/2001
1	fludarabineIBA 05/2001
1	Cladribine FDA LinkGeneric 03/2001
1	Vincristine (Oncovin)FDA LinkGeneric 03/2001
1	Peptide Hydrolases (Proteases)FDA Link 03/2001
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2001
1	Reverse Transcriptase InhibitorsIBA 03/2001
1	Melphalan (Alkeran)FDA LinkGeneric 01/2001
1	Enoxaparin (Lovenox)FDA LinkGeneric 10/2000
1	AcenocoumarolIBA 10/2000
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 10/2000
1	AnticoagulantsIBA 10/2000
1	Pharmaceutical PreparationsIBA 01/2000
1	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 01/2000
1	HaptensIBA 01/2000

Therapy/Procedure

7	Therapeutics 01/2018 - 01/2000
5	Stem Cell Transplantation 04/2017 - 01/2007
5	Drug Therapy (Chemotherapy) 07/2012 - 01/2001
3	Transplantation 01/2021 - 06/2010
2	Hematopoietic Stem Cell Transplantation 01/2021 - 01/2018
2	Induction Chemotherapy 10/2015 - 03/2009
1	MDC protocol 04/2014
1	Intravenous Administration 07/2012
1	ESHAP regimen 05/2008
1	Consolidation Chemotherapy 06/2001
1	Artificial Respiration (Mechanical Ventilation) 05/2001
1	Highly Active Antiretroviral Therapy (HAART) 03/2001
1	Drug Tapering 01/2001
1	Combination Drug Therapy (Combination Chemotherapy) 01/2001
1	Kidney Transplantation 03/2000